ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

ClinicalTrials.gov ID: NCT06287528

Public ClinicalTrials.gov record NCT06287528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Trial of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells That Constitutively Secrete Interleukin 18 (19-28z/IL-18) in Patients With Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Study identification

NCT ID
NCT06287528
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
18 participants

Conditions and interventions

Eligibility (public fields only)

Age range
17 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 22, 2024
Primary completion
Feb 22, 2028
Completion
Feb 22, 2028
Last update posted
Feb 9, 2026

2024 – 2028

United States locations

U.S. sites
7
U.S. states
2
U.S. cities
7
Facility City State ZIP Site status
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 Recruiting
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 Recruiting
Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities) Commack New York 11725 Recruiting
Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York 10604 Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 Recruiting
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06287528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06287528 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →